Drug recall · April 13, 2022
TETRACAINE 1% Tetracaine HCI Injection recall
Why: Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
TETRACAINE 1% Tetracaine HCI Injection, USP, 20mg/2mL (10mg/mL), 10 x 2ml Single Use Vials per box, Rx only, Manufactured for Cameron Pharmaceuticals, LLC., NDC 42494-437-10.
- Lots / codes
Lot #: 21VTHI017, 21VTHI018, 21VTHI019, Exp 5/31/2023
- Quantity
- 722 boxes
- Company
- Vitae Enim Vitae Scientific, Inc., San Diego, CA
- Distribution
- Nationwide in the U.S.A
- Initiated
- March 14, 2022 · Voluntary: Firm initiated
- Classified
- April 5, 2022
- Reported
- April 13, 2022
- Ended
- August 15, 2024
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tetracaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.